#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diffuse large B-cell lymphoma Medulloblastoma Glomerulonephritis chronic Transitional cell cancer of the renal pelvis and ureter Crigler-Najjar syndrome Asthma Antisynthetase syndrome Marginal zone lymphoma refractory Cortical dysplasia Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Chronic cutaneous lupus erythematosus Plasma cell myeloma recurrent Amyloidosis Inflammatory myofibroblastic tumour Kidney transplant rejection More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Trials in Disease Alveolar rhabdomyosarcoma – Life with Disease Nephroblastoma Bronchopulmonary dysplasia – Basic Information Brain stem glioma – Treatment Leiomyosarcoma metastatic – Basic Information Netherton’s syndrome – Life with Disease Hyperoxaluria – Trials in Disease Hereditary ataxia – Treatment Focal segmental glomerulosclerosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Axitinib Moxifloxacin Hydrochloride Dicloxacillin Ropivacaine Ziclumeran Ergocalciferol Camonsertib Choriogonadotropin Alfa Specific Nucleic Acid Sna-Xfsb Trabectedin Tisotumab Vedotin Emapalumab 10-1074-Ls HALOBETASOL PROPIONATE Xylitol Ads-010 Clascoterone CHLOROQUINE PHOSPHATE Avibactam Bbp-398 More therapies…

    Learn about Your Condition

    Hydrocele Breast conserving surgery Pulmonary venous thrombosis Colorectal cancer stage II Retroperitoneal fibrosis Mucous membrane pemphigoid Congenital ureteric anomaly Osteoarthritis Combined immunodeficiency Drug use disorder Cartilage injury Migraine without aura Red blood cell abnormality Mesothelioma malignant Short stature More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Type 1 diabetes mellitus

  • Study on Anti-T Lymphocyte Immunoglobulin for Children and Young Adults with Recent Type 1 Diabetes to Preserve Beta Cell Function

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Czechia

  • Study on the Effect of Influenza Vaccine on Preserving Beta Cell Function in Early Type 1 Diabetes Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • B/Washington/02/2019 – Like Virus (B/Washington/02/2019, Wild Type)
    • Influenza A Virus, A/Cambodia/E0826360/2020 (H3N2) – Like Strain (A/Tasmania/503/2020, Ivr-221), Inactivated
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    Denmark

  • Effect of Verapamil Hydrochloride on Beta Cell Function in Children and Adults Aged 7‑45 with Stage 1 or Stage 2 Type 1 Diabetes (48‑Week Study)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Verapamil Hydrochloride
    France

  • Study of the efficacy and safety of ladarixin and rabbit anti-human thymocyte immunoglobulin in adolescents and adults with new-onset type 1 diabetes

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Ladarixin
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    Italy

  • A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Chronic kidney disease
    Investigated Drugs:
    • SC0062
    • Dapagliflozin
    Denmark Finland The Netherlands

  • Study on Aspirin’s Effect on Platelet Aggregation in Patients with Type 1 Diabetes, Atherosclerotic Cardiovascular Disease, and Diabetic Kidney Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    • Type 1 diabetes mellitus
    • Arteriosclerosis
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!